Dry Eye Awareness

OC-01 0.03 mg nasal spray is effective against dry eye disease regardless of menopausal status

According to investigators, the risk for the development of dry eye disease is greater in postmenopausal women compared with those who have not reached menopause as a result of hormonal dysregulation of the ocular secretory glands.

Okyo Pharma announces IND filing for OK-101 for the treatment of dry eye disease

According to the company, the OK-101 phase 2 trial will incorporate primary and secondary efficacy endpoints characterizing signs and symptoms of dry eye disease.

TearCare System provides greater symptom relief from MGD

According to Jennifer Loh, MD, women achieve significantly better symptom relief than men.